Cargando…
The GPCR Antagonistic Drug CM-20 Stimulates Mitochondrial Activity in Human RPE Cells
BACKGROUND: Mitochondrial dysfunction in retinal pigment epithelium (RPE) is a pathogenic factor in age-related macular degeneration (AMD). Improvement of mitochondrial function may ameliorate RPE bioenergetics status, which may in turn nourish the retinal photoreceptors against degenerative loss. O...
Autores principales: | Chang, Qing, Chen, Siquan, Yang, Tahua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460984/ https://www.ncbi.nlm.nih.gov/pubmed/36090845 http://dx.doi.org/10.2174/1874091X-v16-e2206270 |
Ejemplares similares
-
Activation of LXRs Reduces Oxysterol Lipotoxicity in RPE Cells by Promoting Mitochondrial Function
por: Xie, Lirong, et al.
Publicado: (2022) -
Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies
por: Scott, Martin J., et al.
Publicado: (2020) -
Osmotic induction of cyclooxygenase-2 in RPE cells: Stimulation of inflammasome activation
por: Messerschmidt, Luise, et al.
Publicado: (2019) -
Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates
por: Baker, Jillian G., et al.
Publicado: (2007) -
Tools for GPCR drug discovery
por: Zhang, Ru, et al.
Publicado: (2012)